Optimising utilisation of GLASS data to inform cross-border antimicrobial resistance strategy is a priority

• Scott John Charles Pallett,
• Esmita Charani,
• Georgia Lamb,
• Andrea Mazzella,
• Saleh A. Alqahtani,
• Luke Stephen Prockter Moore

Affiliations

Scott John Charles Pallett

Centre of Defence Pathology, Royal Centre for Defence Medicine, Edgbaston, Birmingham B15 2WB, UK; Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK; Corresponding author. Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK.

Esmita Charani

Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa

Georgia Lamb

Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK

Andrea Mazzella

Infection and Immunity Clinical Academic Group, St George's University Hospitals NHS Foundation Trust, Blackshaw Road, London SW17 0QT, UK

Saleh A. Alqahtani

Division of Gastroenterology & Hepatology, Johns Hopkins University, Baltimore, MD, United States of America; Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Luke Stephen Prockter Moore

Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK